Editorial: Metabolic engineering and synthetic biology for sustainable microbial cell factories. [PDF]
Sankaranarayanan M +2 more
europepmc +1 more source
Immunotoxin WPD101a as a Potential Drug Candidate for Targeted Therapy in Muscle Invasive Bladder Cancer Expressing IL-13Rα2-In Vitro Study. [PDF]
Klimczak A +11 more
europepmc +1 more source
Assessment of the Effects of Single-Domain Anti-Idiotypic Distribution Enhancers on the Disposition of Trastuzumab and on the Efficacy of a PE24-Trastuzumab Immunotoxin. [PDF]
Chen P +3 more
europepmc +1 more source
Evaluation of the Safety of A Novel Anti-HER2 Immunotoxin Containing Modified Fragment of <i>Pseudomonas</i> Exotoxin in BALB/C Mice. [PDF]
Saadatkhah F +4 more
europepmc +1 more source
Ribosome-Inactivating Proteins from <i>Salsola soda</i> L. and <i>Saponaria officinalis</i> L. Are Promising Candidates for Targeted Therapy of Colon Cancer. [PDF]
Biscotti F +8 more
europepmc +1 more source
A conceptual exploration on the synergistic anti-tumor effects of high-order combination of OHSV2-DSTEFAP5/CD3, CAR-T cells, and immunotoxins in hepatocellular carcinoma. [PDF]
Dong S +15 more
europepmc +1 more source
A new treatment for canine B-cell lymphoma based on a recombinant single-domain antibody immunotoxin derived from <i>Pseudomonas aeruginosa</i> exotoxin A. [PDF]
André AS +16 more
europepmc +1 more source
Clinically approved immunotoxins targeting hematological cancers: "the best of both worlds". [PDF]
Rashad Y +4 more
europepmc +1 more source

